Compare ARK Genomic Revolution ETF (ARKG) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Sprott Uranium Miners ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Sprott Uranium Miners ETF trades at $52.7. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | URNM | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $83.99 |
52-Week Low | $23.09 | $44.14 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
URNM trades at $53.29, up 2.07% today, but faces bearish technical signals with 15 sell indicators versus 4 buy signals. The uranium miner ETF benefits from AI-driven power demand, with Seeking Alpha highlighting a 'nuclear renaissance' thesis (June 12, 2026), though concentration in miners like Cameco poses risks. Financial ratios are unavailable, limiting fundamental clarity.
Outlook hinges on uranium supply-demand dynamics and AI energy needs, but technical weakness and mixed sentiment suggest cautious entry. Risks include miner concentration and spot price volatility, while institutional interest in nuclear energy offers long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
